BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37209019)

  • 1. Expression pattern of long non-coding RNAs MALAT1 and MEG3 in COVID-19 patients.
    Genena SESR; Fadhil MM; Mansour MM; Attwa AHM; Khalil MMIM
    J Gene Med; 2023 Sep; 25(9):e3532. PubMed ID: 37209019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21.
    Na L; Ding H; Xing E; Gao J; Liu B; Wang H; Yu J; Yu C
    J Clin Lab Anal; 2020 Apr; 34(4):e23123. PubMed ID: 31907972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of long non-coding RNA maternally expressed gene 3 with microRNA-21 and their correlation with acute ischemic stroke risk, disease severity and recurrence risk.
    Liu C; Huang H; Li Y; Zhao H
    Clin Neurol Neurosurg; 2021 Nov; 210():106940. PubMed ID: 34607195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
    Gao W
    Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients.
    Liu W; Geng F; Yu L
    J Clin Lab Anal; 2020 Jun; 34(6):e23222. PubMed ID: 32309886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of circulating long non-coding RNA MALAT1 in diagnosis, disease surveillance, and prognosis of acute ischemic stroke.
    Ren H; Wu F; Liu B; Song Z; Qu D
    Braz J Med Biol Res; 2020; 53(12):e9174. PubMed ID: 33111743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Expression of Infection-Related Long Noncoding RNAs among COVID-19 Patients: A Case-Control Study.
    Firoozi Z; Mohammadisoleimani E; Bagheri F; Taheri A; Pezeshki B; Naghizadeh MM; Daraei A; Karimi J; Gholampour Y; Mansoori Y; Montaseri Z
    Genet Res (Camb); 2024; 2024():3391054. PubMed ID: 38389521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
    Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
    Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs TUG1 and MEG3 in patients with type 2 diabetes and their association with endoplasmic reticulum stress markers.
    Heydari N; Sharifi R; Nourbakhsh M; Golpour P; Nourbakhsh M
    J Endocrinol Invest; 2023 Jul; 46(7):1441-1448. PubMed ID: 36662419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of long non-coding RNA MALAT1 correlates with raised acute respiratory distress syndrome risk, disease severity, and increased mortality in sepstic patients.
    Huang X; Zhao M
    Int J Clin Exp Pathol; 2019; 12(5):1877-1887. PubMed ID: 31934011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis.
    Shaker OG; Mahmoud RH; Abdelaleem OO; Ibrahem EG; Mohamed AA; Zaki OM; Abdelghaffar NK; Ahmed TI; Hemeda NF; Ahmed NA; Mansour DF
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30514825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinically relevant serum proteins as biomarkers for monitoring COVID-19 severity, and end-organ damage among hospitalized unvaccinated patients.
    Elhommosani MR; Sakr MM; Abbas RM; Aboshanab KM
    BMC Infect Dis; 2024 Feb; 24(1):231. PubMed ID: 38378528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy.
    Perisset S; Potilinski MC; Gallo JE
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation While Stimulates Neurite Outgrowth and Its Correlation With MiR-125b Mediates PTGS2, CDK5 and FOXQ1 in Alzheimer's Disease.
    Ma P; Li Y; Zhang W; Fang F; Sun J; Liu M; Li K; Dong L
    Curr Alzheimer Res; 2019; 16(7):596-612. PubMed ID: 31345147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA MALAT1 Protects Human Osteoblasts from Dexamethasone-Induced Injury via Activation of PPM1E-AMPK Signaling.
    Fan JB; Zhang Y; Liu W; Zhu XH; Xu DW; Zhao JN; Cui ZM
    Cell Physiol Biochem; 2018; 51(1):31-45. PubMed ID: 30439702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel circulating biomarker lnc-MALAT1 for acute myocardial infarction: Its relationship with disease risk, features, cytokines, and major adverse cardiovascular events.
    Li R; Jin J; Liu E; Zhang J
    J Clin Lab Anal; 2022 Dec; 36(12):e24771. PubMed ID: 36378551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease.
    Lv F; Liu L; Feng Q; Yang X
    J Clin Lab Anal; 2021 Apr; 35(4):e23593. PubMed ID: 33660877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
    Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
    Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
    J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
    Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
    BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.